Vitamins &
Supplements

Pharmaceutical-Grade Vitamins & Supplements for Hospitals & International Buyers

Pharmaceutical-grade vitamin and supplement supply is fundamentally different from consumer health retail. Hospitals, clinical nutrition teams, transplant units and international procurement offices require licensed medicinal-grade products with documented provenance, consistent dosing and, where applicable, temperature-controlled handling. Euro Biom supplies these products to healthcare institutions and wholesale distributors across GCC countries and Africa, sourcing from MHRA-licensed UK manufacturers and wholesalers.

Fat-soluble vitamins have important clinical applications beyond general supplementation. Vitamin A (retinol) is used therapeutically in deficiency states, which remain prevalent in parts of sub-Saharan Africa and in malnourished patients. Vitamin D as colecalciferol is available in multiple strengths: 400IU, 800IU, 1000IU and 20,000IU capsules for supplementation, and 300,000IU intramuscular injection for rapid correction of severe deficiency. Vitamin E (tocopherol) is used in premature neonates and certain malabsorption conditions. Vitamin K as phytomenadione (Konakion) injection is essential for neonatal prophylaxis against haemorrhagic disease of the newborn and for urgent reversal of warfarin anticoagulation in bleeding patients.

Injectable and High-Dose B Vitamins for Clinical Use

Water-soluble vitamins in injectable and high-dose oral forms are among the most clinically critical products in this category. Thiamine (vitamin B1) IV, supplied as Pabrinex intravenous high potency injection, is a life-saving treatment for Wernicke's encephalopathy in patients with alcohol dependence or prolonged vomiting. It is also used in critical care for refeeding syndrome prevention. Pabrinex has experienced recurring UK shortage episodes, making reliable export supply particularly important for GCC hospitals managing high-risk patients.

Folic acid 5mg tablets are used therapeutically for megaloblastic anaemia due to folate deficiency and as prophylaxis in pregnancy, particularly in women at higher risk of neural tube defects. Hydroxocobalamin intramuscular injection (1mg/1ml) is the standard treatment for confirmed vitamin B12 deficiency, including pernicious anaemia and dietary B12 deficiency common in vegetarian and vegan populations. Pyridoxine (B6) and riboflavin (B2) are used in specific inherited metabolic conditions and are also components of parenteral nutrition regimens. Ascorbic acid (vitamin C) IV is used in critical care, burns management and where rapid repletion is required.

Minerals and electrolytes in injectable and clinical-grade oral forms are core to hospital pharmacy supply. Iron preparations include ferrous sulphate and ferrous fumarate tablets for oral replacement, and intravenous iron products including ferric carboxymaltose (Ferinject), iron sucrose (Venofer) and iron dextran for patients who cannot absorb oral iron or require rapid repletion. Iron deficiency anaemia affects an estimated 40 percent of women of childbearing age in sub-Saharan Africa, creating sustained demand for both oral and IV iron formulations. Magnesium sulphate IV is used in eclampsia and pre-eclampsia management, in torsades de pointes arrhythmia and in severe asthma, and has been subject to periodic UK shortage alerts. Zinc supplements in oral and IV trace element form are used in deficiency states, wound healing and parenteral nutrition.

Electrolyte and intravenous nutrition products overlap with the vitamins category in hospital formulary management. Sodium chloride infusions, potassium chloride concentrate for dilution, compound sodium lactate (Hartmann's solution) and calcium gluconate IV are all core hospital products that Euro Biom can supply alongside vitamins and minerals. Parenteral nutrition additive components, including trace element solutions and water-soluble vitamin preparations for adding to total parenteral nutrition (TPN) bags, are also within our sourcing capability for specialist nutrition units.

Vitamin D deficiency is exceptionally prevalent in GCC countries, driven by limited sun exposure due to cultural clothing practices, sun avoidance behaviour, high rates of obesity and darker skin pigmentation in expatriate populations. Studies in Saudi Arabia, the UAE and Qatar have reported deficiency rates of 60 to 80 percent in some population groups. This creates very high institutional demand for colecalciferol in multiple strengths. Iron deficiency anaemia is the most common nutritional deficiency worldwide and is disproportionately prevalent in African countries. B12 deficiency is common in South Asian populations in GCC countries. Euro Biom understands these regional epidemiological patterns and stocks accordingly.

Clinical-grade vitamins and minerals are licensed medicinal products, not food supplements. Hospital buyers require products manufactured to pharmaceutical Good Manufacturing Practice (GMP) standards, with full batch documentation, shelf life guarantees and cold chain compliance where required. Consumer-grade supplements sold in health food stores do not meet these standards and are not appropriate for clinical use. Euro Biom supplies only licensed pharmaceutical-grade products sourced from MHRA-regulated supply chains, ensuring that GCC and African hospital buyers receive products that meet the same standards as those used in UK NHS hospitals.

Several therapeutic vitamins and minerals have been subject to serious UK and European supply shortages in recent years. IV thiamine (Pabrinex), phytomenadione (vitamin K) injection, IV magnesium sulphate and certain iron infusion products have all featured on MHRA shortage lists. GCC and African hospitals that rely on local or regional distributors for these products are particularly vulnerable when shortages occur. Euro Biom's access to the UK wholesale market and its network of licensed suppliers allows it to identify alternative sources quickly and fulfil urgent orders, providing continuity of supply for products where interruption could directly affect patient safety.